Document is current
Any future updates will be listed below
-
Authors
Stewart, Daniel C.
Brisson, Becky K.
Dekky, Bassil
Berger, Ashton C. https://orcid.org/0000-0001-5195-2528
Yen, William
Mauldin, Elizabeth A.
Loebel, Claudia
Gillette, Deborah
Assenmacher, Charles-Antoine
Quincey, Corisa
Stefanovski, Darko
Cristofanilli, Massimo https://orcid.org/0000-0002-4194-7175
Cukierman, Edna
Burdick, Jason A. https://orcid.org/0000-0002-2006-332X
Borges, Virginia F. https://orcid.org/0000-0003-1158-7524
Volk, Susan W. https://orcid.org/0000-0003-3993-4145
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R21CA216552)
- License Information
-
More Information
Article History
Received: 26 February 2023
Accepted: 3 September 2024
First Online: 2 October 2024
Competing interests
: S.W.V. is inventor on an issued US patent (No. 10,286,043) regarding technology related to the use of Col3 to suppress cancer metastasis and local recurrence. The remaining authors declare no competing interests.
